RxDoctor Payments Data

Sharad Mansukani

Ophthalmology · Moorestown, NJNPI 1386980175

Payments from drug & device makers

What this record shows

The money is spread across several categories — ownership interests (32.2%), consulting fees and other — rather than concentrated in one kind of arrangement. Reporting peaked in 2019 at $447,701 and has fallen 67.3% since, to $146,484 in 2023. Among ophthalmology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$744,356in general payments, 2019–2025

Across 54 payments — averaging $13,784 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endo Pharmaceuticals Inc.$408K
  • Immucor, Inc.$336K

What the payments were for

  • Consulting fees$207,12028%
  • Speaking & faculty fees$120,00016%
  • Travel & lodging$45,2916%
  • Food & beverage$2,5810%
  • Ownership interest$240,00032%
  • Other$129,36417%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Endo Pharmaceuticals Inc.47$407,872
Immucor, Inc.7$336,484

How this compares

$744,356 in reported general payments places this provider in the 95th percentile of 583 ophthalmology providers in New Jersey.

See all ophthalmology providers in New Jersey

Other ophthalmology in Moorestown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →